ארצות הברית - אנגלית - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene gel is indicated for the topical treatment of acne vulgaris. adapalene gel should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle gel.

קנדה - אנגלית - Health Canada

taro pharmaceuticals inc - adapalene; benzoyl peroxide - gel - 0.1%; 2.5% - adapalene 0.1%; benzoyl peroxide 2.5% - keratolytic agents

קנדה - אנגלית - Health Canada

taro pharmaceuticals inc - adapalene; benzoyl peroxide - gel - 0.3%; 2.5% - adapalene 0.3%; benzoyl peroxide 2.5% - keratolytic agents

ארצות הברית - אנגלית - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene gel, 0.3% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. adapalene gel is contraindicated in patients who have known hypersensitivity to adapalene or any excipient of adapalene gel [see warnings and precautions (5.1)]. risk summary available data from clinical trials with adapalene gel use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. in animal reproduction studies, oral administration of adapalene to pregnant rats and rabbits during organogenesis at dose exposures 40 and 81 times, respectively, the human exposure at the maximum recommended human dose (mrhd) of 2 g resulted in fetal skeletal and visceral malformations (see data) . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defects, loss, or other adverse outcomes. in the u.s. general population

ארצות הברית - אנגלית - NLM (National Library of Medicine)

encube ethicals private limited - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene gel, 0.3% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. adapalene gel, 0.3% is contraindicated in patients who have known hypersensitivity to adapalene or any excipient of adapalene gel, 0.3% [see warnings and precautions (5.1) ]. risk summary available data from clinical trials with adapalene gel, use in pregnant women are insufficient to establish a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. in animal reproduction studies, oral administration of adapalene to pregnant rats and rabbits_ during organogenesis at dose exposures 40 and 81 times, respectively, the human exposure at the maximum recommended human dose (mrhd) of 2 g resulted in fetal skeletal and visceral malformations ( see data). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defects

ארצות הברית - אנגלית - NLM (National Library of Medicine)

bryant ranch prepack - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene cream is indicated for the topical treatment of acne vulgaris. adapalene cream should not be administered to individuals who are hypersensitive to adapalene or any of the components in the cream vehicle.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

mayne pharma inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - adapalene cream is indicated for the topical treatment of acne vulgaris. adapalene cream should not be administered to individuals who are hypersensitive to adapalene or any of the components in the cream vehicle.

ארצות הברית - אנגלית - NLM (National Library of Medicine)

marnel pharmaceuticals, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf) - indications and usage:   plixda (adapalene) topical solution, 0.1% should not be administered to individuals who are hypersensitive to adapalene or any of the components in the vehicle solution.

קנדה - צרפתית - Health Canada

taro pharmaceuticals inc - adapalène; peroxyde de benzoyle - gel - 0.1%; 2.5% - adapalène 0.1%; peroxyde de benzoyle 2.5% - keratolytic agents

צרפת - צרפתית - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

zentiva france - adapalène 0 - crème - 0,1 g - pour 100 g de crème > adapalène 0,1 g - antiacneique local - classe pharmacothérapeutique : antiacneique local, code atc: d10ad03(d. dermatologie)ce médicament est utilisé dans le traitement de l'acné de sévérité moyenne, particulièrement dans l’acné rétentionnelle.